Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.4589
+0.0080 (1.77%)
Apr 16, 2026, 9:12 AM EDT - Market open
Gossamer Bio Market Cap
Gossamer Bio has a market cap or net worth of $107.7 million as of April 16, 2026. Its market cap has decreased by -56.91% in one year.
Market Cap
107.70M
Enterprise Value
171.80M
1-Year Change
-56.91%
Ranking
Category
Stock Price
$0.46
Market Cap Chart
Since February 8, 2019, Gossamer Bio's market cap has decreased from $995.26M to $107.70M, a decrease of -89.18%. That is a compound annual growth rate of -26.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 15, 2026 | 105.82M | -85.25% |
| Dec 31, 2025 | 717.51M | 250.03% |
| Dec 31, 2024 | 204.99M | -0.34% |
| Dec 29, 2023 | 205.69M | 0.56% |
| Dec 30, 2022 | 204.54M | -76.06% |
| Dec 31, 2021 | 854.34M | 21.87% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 102.73M |
| Turn Therapeutics | 98.75M |
| eXoZymes | 97.51M |
| Verrica Pharmaceuticals | 96.54M |
| Anixa Biosciences | 95.55M |
| LeonaBio | 91.21M |
| Inovio Pharmaceuticals | 89.31M |
| Vivani Medical | 88.88M |